Lung Cancer Screening Market, Size, Global Forecast 2022-2027
In recent years, lung cancer screening has enabled the detection of lung cancer before symptoms begin. Besides, the main aim of lung cancer screening is to detect lung cancer at its earliest and most treatable stage. Collectively, screening tests involve lab tests that monitor blood and other fluids, genetic tests that study for inherited genetic markers associated with illness, and imaging exams that produce pictures of the inside of the body. In addition, in lung cancer screening, individuals who have a high risk of developing lung cancer but no signs or symptoms of the disease undergo low-dose computed tomography (LDCT) scanning of the chest. According to the Renub Research estimates, Lung Cancer Screening Market is projected to reach US$ 16.7 Billion by 2027.
